N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity

NCT00267384 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Drug Induced Nephrotoxicity

Interventions

DRUG: Oral N-Acetylcysteine

Sponsor

Soroka University Medical Center